Carcinoid Syndrome: Updates in Pathophysiology, Diagnosis, and Treatment
Posted by...Bernard Sklar, MD.
Free Gastroenterology CME Credit Hours...1.0.
CME Credits Awarded by....ScientiaCME.
Instruction Type...Slide-Video Lectures.
Target Audience...Gastroenterologists and primary care physicians; physician assistants, nurse practitioners, nurses, and pharmacists who practice in gastroenterology; and any other healthcare professionals with an interest in or who clinically encounter patients with chronic idiopathic constipation.
Educational material updated...October 02, 2017.
Expiration of CME credit...October 02, 2019.
Financial Support...Synergy Pharmaceuticals.
Chronic Idiopathic Constipation (CIC)
discusses conventional therapies: bulking agents, softeners, stimulants, osmotics; recent additions and investigational agents: prucalopride, plecanatide, linaclotide, lubiprostone; non-pharmacologic therapies and their place relative to pharmacotherapy: dietary, mechanical, behavioral, and surgical interventions; biofeedback; and clinical pearls and difficult-to-treat cases.
After reviewing Chronic Idiopathic Constipation (CIC)
, you will be able to:
• Describe the pathophysiology of chronic idiopathic constipation
• Describe the benefits and risks of pharmacotherapy for chronic idiopathic constipation and take them into account when formulating a treatment plan for different patients
• Formulate an evidence-based treatment plan for a variety of patients with chronic idiopathic constipation.
• Recommend therapy changes in patients with chronic idiopathic constipation who do not respond to a previously prescribed treatment
In order to receive credit from ScientiaCME, you must first establish a username and password.